Epican
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Epican - overview
Established
2015
Location
Shanghai, Shanghai, China
Primary Industry
Healthcare
About
Based in Shanghai, and established in 2015, Epican is a healthcare company that focuses on the R&D, production, and service of genetic diagnosis products. The company doing business used the name of Zaoyian. The company's founder is professor Chuan He at Chicago University, who majored in gene epigenetic testing technology. The company has 9 patents, including 7 USA patents.
Moreover, the company has undertaken infectious disease prevention and control projects, such as AIDS, and hepatitis. The company developed cancer early diagnosis products that can detect cancer including liver cancer, stomach cancer, intestine cancer, and esophagus cancer by drawing 8mL of blood. The processes used the technology of gene sequencing, chemical label capture, machine learning, and big data.
Current Investors
Comway Capital, Viva Ventures Biotech
Primary Industry
Healthcare
Sub Industries
Biotechnology, Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment
Website
www.jollian.cn
Verticals
Big Data
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.